Patents Assigned to Promethera Biosciences S. A./N.V.
  • Method for producing adult liver progenitor cells
    Patent number: 10538741
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: January 21, 2020
    Assignee: Promethera Biosciences S.A./N.V.
    Inventors: Etienne Sokal, Sarah Snykers, Tuba Baran, Kris Gellynck, Luca Falciola
  • Method for producing adult liver progenitor cells
    Patent number: 10172889
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: January 8, 2019
    Assignee: Promethera Biosciences S.A./N.V.
    Inventors: Etienne Sokal, Sarah Snykers, Tuba Baran, Kris Gellynck
  • METHOD FOR PRODUCING ADULT LIVER PROGENITOR CELLS
    Publication number: 20160206664
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 21, 2016
    Applicant: Promethera Biosciences S. A./N.V.
    Inventors: Etienne SOKAL, Sarah SNYKERS, Tuba BARAN, Kris GELLYNCK